Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00138216
Recruitment Status : Completed
First Posted : August 30, 2005
Last Update Posted : February 20, 2014
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group